Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Interim Results of HGP-30 AIDS Vaccine Study ALEXANDRIA, Va., Oct. 30, 1996 -- In response to multiple investor inquiries, CEL-SCI CORPORATION (Nasdaq: CELI) announces interim results of its Phase I safety study with the HGP-30 AIDS vaccine in HIV infected individuals. AIDS ReSearch Alliance, a non-profit AIDS research organization located in West Hollywood, California, is conducting the 24 patient study. The interim analysis at week 10 shows the first two administrations of the HGP-30 AIDS vaccine to be safe in HIV infected patients. Proof of safety of HGP-30 in HIV infected individuals is the primary goal this study was designed to achieve. Further, when evaluated as a group, disease stabilization during the 10 week evaluation period was seen in patients with a CD4 count between 300 and 750. The number of patients with a CD4 count between 50 and 300 is too small to make a generalized statement. The study is expected to be completed by the Summer of 1997. Based on these interim results, CEL-SCI Corporation is currently preparing for additional HGP-30 studies in Thailand. Those tests are expected to start in the second half of 1997. Additional studies in the U.S. are also under investigation. At the International Conference on AIDS this past Summer, Dr. James Kahn of San Francisco General Hospital reported protection against HIV infection using the blood of five HGP-30 vaccinated, non-infected volunteers in SCID mice. This is the first time that protection by an AIDS vaccine has been demonstrated with a HIV challenge model. CEL-SCI Corporation is a pioneer in the field of natural immunotherapy. The Company is developing immune based treatments for cancer, AIDS and tuberculosis. Recently, CEL-SCI Corporation signed a collaborative agreement with the U.S. Navy to jointly develop a malaria vaccine and a collaboration agreement with Northeastern Ohio University College of Medicine to jointly develop a herpes vaccine. E-mail this page to a friend or colleague! To print, use this version